在压力过重的情况下,PKM1在心脏重塑中发挥关键作用
Qinfeng Li1,2,3, Chao Li3, Abdallah Elnwasany3
1Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, China (Q.L., J.Lin, Y.G., M.W., G.F.).
Circulation
|June 9, 2021
概括
在压力下维持心脏功能至关重要. 减少PKM1会恶化心脏功能障碍,而过度表达则通过支持葡萄糖代谢来防止心脏衰竭.
科学领域:
- 心脏病学
- 代谢调节
- 分子生物学
背景情况:
- 心脏缩的增长涉及代谢重塑,其中葡萄糖利用率增加是关键特征.
- 在压力过度诱导的心脏缩和心力衰竭中,心脏酸酶异酶1 (PKM1) 的确切作用尚不完全理解.
研究的目的:
- 研究心脏PKM1在葡萄糖代谢中的作用以及心脏对压力过载的反应.
- 阐明PKM1影响心脏适应血动力应激的分子机制.
主要方法:
- 产生心肌细胞特异性PKM1淘汰和诱导过度表达的小鼠模型.
- 使用横向的大动脉收缩来诱导体内压力过载.
- 在体外研究中使用初级新生小鼠心室肌细胞.
- 进行代谢学和核磁共振光谱分析心脏代谢流量.
主要成果:
- 在衰弱的人和老鼠的心脏中,PKM1的表达下调.
- 在压力过重的情况下,PKM1的损失会加剧心脏功能障碍和纤维化.
- 过度表达PKM1可以保护心脏免受压力过重引起的心肌病.
- PKM1对于增强的糖分流,线粒体呼吸和ATP产生至关重要.
- 缺少PKM1会影响心肌细胞生长和酸盐脱酶复合物的活性.
结论:
- PKM1在心脏对血液动力应激反应中起着至关重要的作用.
- 针对PKM1可能为心力衰竭提供治疗策略.
更多相关视频
相关概念视频
Heart Failure II: Pathophysiology
133
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
133
Pathophysiology of Heart Failure
2.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.1K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
109
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
109
Cardiomyopathy V: Interprofessional Care
93
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
93
Cardiomyopathy II: Dilated Cardiomyopathy
111
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
111
Cardiomyopathy IV: Restrictive Cardiomyopathy
142
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
142


